Main > A1. CORP. INDEX. R-Rm > Regeneron Pharmaceuticals/P C2

---

Regeneron Pharmaceuticals/P C2's subsections
2007. 02.12.2007. (AstraZeneca)
2007. 11.29.2007. (Sanofi Aventis)
2008. 05.21.2008. Onco.>Ovarian C.
2012. 04.05.2012. Onco.>Prostate C.
2012. 07.30.2012. Gout
2012. 11.27. Ophthalmo.>AMD
2013. 02.05. Onco.>Colon C.
2013. 02.11. Sanofi
2013. 03.02. Dermatitis
2013. 04.04. Expansion in NY
2013. 05.03. Acq. 2 Dev. Prog.
2013. 08.07. Patent
2013. 11.22. Rheuma.>RA
2014. 01.13. Genetics Initiative
2014. 05.05. Avalanche Biotech.
2014. 09.22. Ophthalmo.>Myopic CNV
2014. 09.30. Sinusitis>DupiluMAb
2014. 10.20. Atopic Dermatitis
2014. 11.11. Pneumo.>Asthma
2014. 11.18. Ophthalmo.>DME
2015. 02.26. Ophthalmo.>BRVO>ME
2015. 02.26. Ophthalmo.>CRVO>ME
2015. 09.28. CV.>HyperChol>FH
2015. 10.30. Ophthalmo.>Myopic CNV
2016. 08.22. MERS Virus BARDA
2017. 02.01. Rheuma.>RA
2017. 03.28. Derma.>AD
2017. 11.29. Decibel Therapeutics
2018. 08.06. Bluebird Bio
2018. 09.28. Onco.>Skin C.>CSCC
2018. 10.19. Pneumo.>Asthma
2019. 04.08. Alnylam Pharma.
2019. 05.13. Ophthalmo.>DR
2019. 06.26. CRSwNP
2019. 07.01. Onco.>Skin C.>CSCC
2019. 08.06. Atopic Dermatitis
2019. 08.13. USA FDA Approves
2019. 10.29. CRSwNP
2020. 03.17. COVID-19
2020. 03.30. COVID-19
2020. 04.27. COVID-19
2020. 05.26. Derma.>AD>USA>OK
2020. 06.19. Derma.>AD>CN>OK
2020. 06.19. Derma.>AD>USA>OK
2020. 10.14. EbolaVirus>USA FDA>OK
2020. 11.21. COVID-19 Ab .. USA>EUA
2020. 11.30. Derma.>AD>EU>OK
2021. 02.09. Onco.>Advanced BCC
2021. 02.11. Cardio.>HoFH>USA>OK
2021. 07.27. Obesity AstraZeneca
2022. 04.07. Pneumo.>Asthma>EU>OK
2022. 04.19. Acq. Checkmate Pharma
2022. 05.20. Gastro.>EoE>USA>OK
2022. 09.28. Derma.>PN>USA>OK
2022. 11.22. Onco.>Cervical>EU>OK
2022. 12.15. Prurigo nodularis>EU>O
2022. 12.23. Onco.>Cervical>JP>OK
2023. 03.21. Derma.>AD>EU>OK
2023. 03.29. Onco.>NSCLC>EU>OK
2023. 08.09. Acq Decibel Therapeuti
2023. 08.18. Rare>Chaple D.>USA>OK
2023. 09.25. Acq Decibel Therapeuti
2024. 01.25. FDA Approved
2024. 01.30. Regeneron Cell Medicin
2024. 04.01. 2Seventy Bio Inc
2025. 01.03. Acq. OxUlar Ltd
2025. 05.19. Acq. 23andMe
2025. 06.02. Obesity
Patents
Web-Site
Z - OK

Regeneron Pharmaceuticals/P C2's products
This section has no products